Ukraine


COUNTRY PROFILE

Ukraine is a country in Eastern Europe. It has an area of 603,628 km2 (233,062 sq mi), making it the largest country entirely within Europe.

Ukraine borders Russia to the east and northeast, Belarus to the northwest, Poland, Slovakia and Hungary to the west, Romania and Moldova to the southwest, and the Black Sea and Sea of Azov to the south and southeast, respectively.

The territory of modern Ukraine has been inhabited by humans since 32,000 BC. During the Middle Ages, the area was a key center of East Slavic culture, with the powerful state of Kievan Rus' forming the basis of Ukrainian identity. Following its fragmentation in the 13th century, the territory was contested, ruled and divided by a variety of powers, including Lithuania, Poland, the Ottoman Empire, Austro-Hungary, and Russia.A Cossack republic emerged and prospered during the 17th and 18th centuries, but Ukraine's territories remained divided until they were consolidated into a Soviet republic in the 20th century. It became independent in 1991.

SELECT A SECTION:

≡ UKRAINE
Summary | Economy | Doing Business | International Ratings
≡ PHARMACEUTICAL MARKET
Structure & Trends | Regulation | Marketing Authorization | Pharmaceutical Companies | Wholesalers & Distributors | Pharmacies | Publications
≡ HEALTHCARE SYSTEM
Description | Healthcare Infrastructure | Public Spending | Statistics | Publications
≡ PUBLICATIONS
Economics updates | Pharmaceutical market publications | Healthcare publications | Statistical updates

1. HEALTHCARE SYSTEM

a) overview;
b) structure;
c) organizational overview;
d) financial flowchart;
e) expenditures;
f) revenue collection/sources of funds;
g) compulsory sources of finance;
h) out-of-pocket payments;
i) voluntary health insurance;
j) external sources of funds

2. COMMON PHARMA REGULATION ISSUES

a) legislation in pharmaceutical field;
b) marketing authorization and pricing;
c) intellectual property in pharmaceuticals;
d) pre-clinical trials;
e) clinical trials;
f) registration of drugs;
g) procedure of state (re-) registration of medical immunobiological drugs;
h) procedure for state registration of medical equipment and medical products;
i) licensing;
j) certification;
k) labeling;
l) quality control;
m) registration of import;
n) customs procedures;
o) quality control of import;

3. REGULATION OF DRUGS TURNOVER

a) wholesale: (licensing, sale conditions);
b) retail: (licensing, sale conditions);
c) trade patenting;
d) incoming control;
e) storage and transportation;
f) public procurement;
g) pricing;
h) VAT-taxation;
i) advertising.

4. PHARMACEUTICAL MARKET

a) Market Access

5. COMPANIES

a) Manufacturers;
b) Wholesalers/Distributors;
c) Pharmacies;

6. STATISTICS

a) demography;

7. PUBLICATIONS

a) legal;
b) market;
c) healthcare system;
Powered by Blogger.